• BigBear Pharmaceuticals of Laos Successfully Obtains GMP Certification for Its Traditional Medicine Processing Plant

  Laos, October 7, 2023 – BigBear Pharmaceuticals of Laos is pleased to announce that its Traditional Chinese Medicine processing facility has successfu···【Read More】

  Update: 20 May,2026Source: Haiou HealthViews: 290

• FDA Approves Baxfendy (baxdrostat) as the First Aldosterone Synthase Inhibitor Treatment for Adults with Hypertension

  May 18, 2026 – Baxfendy (baxdrostat) from AstraZeneca has received FDA approval as the world's first aldosterone synthase inhibitor (ASI) for use ···【Read More】

  Update: 20 May,2026Source: Haiou HealthViews: 177

• BigBear Pharma Announces Approval of Encorafenib (BRATODX) in Laos

  Vientiane, Laos – October 12, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovativ···【Read More】

  Update: 19 May,2026Source: Haiou HealthViews: 156

• EU Recommends Expanding New Indications for Nivolumab (Opdivo)

  Recently, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending chan···【Read More】

  Update: 19 May,2026Source: Haiou HealthViews: 160

• BigBear Pharma: Rooted in Laos, Aspiring for Global Reach as a Guardian of Public Health

  In Vientiane, the capital city of Laos, a modern pharmaceutical manufacturing base is emerging steadily. As a representative of officially licensed ch···【Read More】

  Update: 18 May,2026Source: Haiou HealthViews: 179

• FDA Approves Immgolis (golimumab-sldi) and Immgolis Intri (golimumab-sldi) as the First Interchangeable Biosimilars to Simponi and Simponi Aria

  May 15, 2026 — The FDA has approved Immgolis (golimumab-sldi) as an interchangeable biosimilar to Simponi (golimumab), and Immgolis Intri (golimumab-s···【Read More】

  Update: 18 May,2026Source: Haiou HealthViews: 131

• BigBear Pharma: Binimetinib (MEKTODX) Receives Approval from the Lao Ministry of Health

  Vientiane, Laos—October 12, 2024—BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer treat···【Read More】

  Update: 14 May,2026Source: Haiou HealthViews: 143

• BigBear Pharma: A Beacon of Health Along the Mekong River, Setting a New Benchmark for Laos’ Pharmaceutical Industry

  In Vientiane, the capital of Laos nourished by the Mekong River, a modern pharmaceutical manufacturing base brims with vigorous vitality. As one of La···【Read More】

  Update: 13 May,2026Source: Haiou HealthViews: 204

• BigBear Pharma: Selpercatinib (SEPADX) approved for marketing by the Lao Ministry of Health

  Vientiane, Laos - November 20, 2023 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer ···【Read More】

  Update: 12 May,2026Source: Haiou HealthViews: 145

• EU Approves New Expanded Indications for Dabrafenib and Trametinib!

  The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending amendmen···【Read More】

  Update: 11 May,2026Source: Haiou HealthViews: 144

• Dual “Zero” Breakthrough! Big Bear Pharma Laos’ Anticancer Drug Exports to ASEAN Economies for the F

  VIENTIANE, LAOS, SEPTEMBER 24, 2024 — Recently, Big Bear Pharma Laos announced that it has obtained official approval from the Lao Ministry of Health ···【Read More】

  Update: 16 Jan,2026Source: Haiou HealthViews: 398

• BigBear Pharmaceuticals (Lao PDR) Successfully Earns GMP Certification for Its Traditional Medicine

  BigBear Pharmaceuticals (Lao PDR) Secures GMP Certification for Traditional Medicine Processing Facility, Elevating Product Quality StandardsVIENTIANE···【Read More】

  Update: 16 Jan,2026Source: Haiou HealthViews: 361

• Lao Food and Drug Administration Conducts Inspection and Guidance at Big Bear Pharma’s Traditional C

  VIENTIANE, VIENTIANE, LAO PDR, July 28, 2023 — The Lao Food and Drug Administration has conducted an inspection and guidance visit to the Traditional ···【Read More】

  Update: 16 Jan,2026Source: Haiou HealthViews: 232

• BigBear Pharma Participates in GMP Quality Improvement Conference Co-hosted by Lao Ministry of Healt

  VIENTIANE, LAO PEOPLE’S DEMOCRATIC REPUBLIC, March 1, 2023 — Representatives of the World Health Organization (WHO) presented the WHO GMP quality cont···【Read More】

  Update: 16 Jan,2026Source: Haiou HealthViews: 244

• BigBearPharma (Lao PDR) Announces All Production Facilities Awarded GMP Certification by Lao FDD

  VIENTIANE, LAO PEOPLE’S DEMOCRATIC REPUBLIC, March 3, 2023 — BigBearPharma has announced that all of its production facilities have obtained the Good ···【Read More】

  Update: 16 Jan,2026Source: Haiou HealthViews: 362